Literature DB >> 5250129

Antibody to Mycoplasma pneumoniae in normal subjects and in patients with chronic bronchitis.

H P Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5250129      PMCID： PMC2130635          DOI： 10.1017/s0022172400041061

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  9 in total

1.  RESPIRATORY SYNCYTIAL VIRUS IN ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS.

Authors:  R G SOMMERVILLE
Journal:  Lancet       Date:  1963-12-14       Impact factor: 79.321

Review 2.  MYCOPLASMA SPECIES OF MAN.

Authors:  L HAYFLICK; R M CHANOCK
Journal:  Bacteriol Rev       Date:  1965-06

3.  EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS.

Authors:  G E ENNY; J T GRAYSTON
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

4.  Growth of Eaton PPLO in broth and preparation of complement fixing antigen.

Authors:  R M CHANOCK; W D JAMES; H H FOX; H C TURNER; M A MUFSON; L HAYFLICK
Journal:  Proc Soc Exp Biol Med       Date:  1962 Aug-Sep

5.  Serologic response to Myocplasma pneumoniae infection. II. Significance of antibody measured by different techniques.

Authors:  D Taylor-Robinson; A Shirai; O Sobĕslavský; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

6.  Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers.

Authors:  C B Smith; W T Friedewald; R M Chanock
Journal:  JAMA       Date:  1967-02-06       Impact factor: 56.272

7.  Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection.

Authors:  D Taylor-Robinson; O Sobĕslavsyý; K E Jensen; L B Senterfit; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

8.  Serologic epidemiologic studies with M. pneumoniae. I. Demonstration of an hemagglutinin and its inhibition by antibody.

Authors:  H A Feldman; R H Suhs
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

9.  Infective agents and chronic bronchitis.

Authors:  C A Ross; S McMichael; M B Eadie; A W Lees; E A Murray; I Pinkerton
Journal:  Thorax       Date:  1966-09       Impact factor: 9.139
  9 in total
  7 in total

1.  Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections.

Authors:  D Lewes; D J Rainford; W F Lane
Journal:  Br Heart J       Date:  1974-09

2.  A search for mycoplasma infections in patients with chronic bronchitis.

Authors:  J D Cherry; D Taylor-Robinson; H Willers; A C Stenhouse
Journal:  Thorax       Date:  1971-01       Impact factor: 9.139

3.  Mycoplasma pneumoniae pneumonia: CT features in 16 patients.

Authors:  Inho Lee; Tae Sung Kim; Hye-Kyung Yoon
Journal:  Eur Radiol       Date:  2005-10-08       Impact factor: 5.315

4.  Severe mycoplasma pneumonia.

Authors:  S Holt; W F Ryan; E J Epstein
Journal:  Thorax       Date:  1977-02       Impact factor: 9.139

5.  Mycoplasma pneumoniae infections.

Authors:  M C Jones
Journal:  Br Med J       Date:  1972-01-01

6.  Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress.

Authors:  Chirag Kariya; Hong Wei Chu; Jie Huang; Heather Leitner; Richard J Martin; Brian J Day
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

Review 7.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.